Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis
Authors:
- Bingya LiuBLBingya Liu
- Qu CaiQCQu Cai
- Jianfang LiJLJianfang Li
- Xuehua ChenXCXuehua Chen
- Zhenggang ZhuZZZhenggang Zhu
- 1 July 2012
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 413 (13-14) , 1098-1106
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30872477, 30901729)
- Shanghai Leading Academic Discipline Project (S30204)
- National HighTech Program (2006AA02A402, 2006AA02A301)
This publication has 25 references indexed in Scilit:
- Searching for serum tumor markers for colorectal cancer using a 2‐D DIGE approachElectrophoresis, 2009
- Down-regulated expression of complement factor I: A potential suppressive protein for gastric cancer identified by serum proteome analysisClinica Chimica Acta, 2007
- Depletion of multiple high‐abundance proteins improves protein profiling capacities of human serum and plasmaProteomics, 2005
- The development of the DIGE system: 2D fluorescence difference gel analysis technologyAnalytical and Bioanalytical Chemistry, 2005
- Identification of the Thrombin Light Chain A as the Single Best Mass for Differentiation of Gastric Cancer Patients from Individuals with Dyspepsia by Proteome AnalysisJournal of Proteome Research, 2005
- Identification of Gastric Cancer Patients by Serum Protein ProfilingJournal of Proteome Research, 2004
- Diverse proteomic alterations in gastric adenocarcinomaProteomics, 2004
- Gastric cancer treatment guidelines in JapanGastric Cancer, 2002
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- CEA, CA 19-9, and CA-50 in Monitoring Gastric CarcinomaAmerican Journal of Clinical Oncology, 1997